NEA Management Company’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,376,936
| Closed | -$13M | – | 59 |
|
|
2022
Q1 | $13M | Hold |
10,376,936
| – | – | 0.37% | 36 |
|
|
2021
Q4 | $12M | Hold |
10,376,936
| – | – | 0.24% | 42 |
|
|
2021
Q3 | $19.9M | Hold |
10,376,936
| – | – | 0.24% | 37 |
|
|
2021
Q2 | $24.3M | Hold |
10,376,936
| – | – | 0.32% | 39 |
|
|
2021
Q1 | $28.1M | Hold |
10,376,936
| – | – | 0.63% | 34 |
|
|
2020
Q4 | $25.1M | Hold |
10,376,936
| – | – | 0.66% | 28 |
|
|
2020
Q3 | $23.8M | Buy |
10,376,936
+3,151,260
| +44% | +$7.22M | 1.01% | 26 |
|
|
2020
Q2 | $16.6M | Hold |
7,225,676
| – | – | 0.67% | 26 |
|
|
2020
Q1 | $12.4M | Hold |
7,225,676
| – | – | 0.65% | 25 |
|
|
2019
Q4 | $15M | Hold |
7,225,676
| – | – | 0.71% | 24 |
|
|
2019
Q3 | $21M | Hold |
7,225,676
| – | – | 1.74% | 18 |
|
|
2019
Q2 | $28.3M | Buy |
7,225,676
+2,857,142
| +65% | +$11.2M | 1.98% | 18 |
|
|
2019
Q1 | $20.6M | Buy |
4,368,534
+1,243,534
| +40% | +$5.87M | 1.07% | 23 |
|
|
2018
Q4 | $7.17M | Hold |
3,125,000
| – | – | 0.28% | 34 |
|
|
2018
Q3 | $19.5M | Hold |
3,125,000
| – | – | 0.84% | 28 |
|
|
2018
Q2 | $21.3M | Hold |
3,125,000
| – | – | 1% | 22 |
|
|
2018
Q1 | $26.3M | Buy |
+3,125,000
| New | +$26.3M | 1.17% | 21 |
|